$1.76 Billion is the total value of Eventide Asset Management's 136 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 12.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XPO | XPO LOGISTICS INC | $59,918,000 | +4.9% | 884,000 | 0.0% | 3.40% | -4.5% | |
| BLUE | Sell | BLUEBIRD BIO INC | $56,588,000 | -5.4% | 412,000 | -27.7% | 3.21% | -13.9% |
| MIC | Buy | MACQUARIE INFRASTRUCTURE COR | $52,771,000 | -7.5% | 731,100 | +0.5% | 2.99% | -15.8% |
| ABBV | Sell | ABBVIE INC | $49,273,000 | +21.9% | 554,500 | -0.5% | 2.79% | +11.0% |
| LOW | LOWES COS INC | $45,166,000 | +3.1% | 565,000 | 0.0% | 2.56% | -6.1% | |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $43,665,000 | +145.8% | 1,204,540 | +88.2% | 2.48% | +123.8% |
| LRCX | LAM RESEARCH CORP | $42,004,000 | +30.8% | 227,000 | 0.0% | 2.38% | +19.1% | |
| CELG | Sell | CELGENE CORP | $39,998,000 | +0.9% | 274,300 | -10.2% | 2.27% | -8.1% |
| W | WAYFAIR INCcl a | $38,081,000 | -12.3% | 565,000 | 0.0% | 2.16% | -20.2% | |
| WBC | WABCO HLDGS INC | $37,829,000 | +16.1% | 255,600 | 0.0% | 2.14% | +5.7% | |
| STKL | SUNOPTA INC | $33,817,000 | -14.7% | 3,887,000 | 0.0% | 1.92% | -22.3% | |
| TTD | Buy | THE TRADE DESK INC | $33,461,000 | +36.3% | 544,000 | +11.0% | 1.90% | +24.0% |
| AVXS | AVEXIS INC | $32,843,000 | +17.7% | 339,529 | 0.0% | 1.86% | +7.1% | |
| MGA | Buy | MAGNA INTL INC | $32,482,000 | +16.0% | 608,500 | +0.7% | 1.84% | +5.6% |
| NEP | Sell | NEXTERA ENERGY PARTNERS LP | $31,910,000 | +8.1% | 792,000 | -0.8% | 1.81% | -1.6% |
| LEA | LEAR CORP | $31,847,000 | +21.8% | 184,000 | 0.0% | 1.80% | +10.9% | |
| CCI | Sell | CROWN CASTLE INTL CORP NEW | $30,694,000 | -0.4% | 307,000 | -0.2% | 1.74% | -9.3% |
| STLD | Sell | STEEL DYNAMICS INC | $30,023,000 | -11.7% | 871,000 | -8.3% | 1.70% | -19.6% |
| ASML | Sell | ASML HOLDING N V | $29,446,000 | +13.0% | 172,000 | -14.0% | 1.67% | +2.8% |
| WCN | WASTE CONNECTIONS INC | $29,383,000 | +8.6% | 420,000 | 0.0% | 1.66% | -1.1% | |
| ONCE | Buy | SPARK THERAPEUTICS INC | $28,888,000 | +222.4% | 324,000 | +116.0% | 1.64% | +193.4% |
| SGEN | SEATTLE GENETICS INC | $28,565,000 | +5.2% | 525,000 | 0.0% | 1.62% | -4.3% | |
| INST | Buy | INSTRUCTURE INC | $27,912,000 | +41.2% | 842,000 | +25.7% | 1.58% | +28.5% |
| KAR | KAR AUCTION SVCS INC | $27,546,000 | +13.7% | 577,000 | 0.0% | 1.56% | +3.5% | |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $27,367,000 | +513.7% | 180,000 | +420.2% | 1.55% | +457.9% |
| LOXO | Sell | LOXO ONCOLOGY INC | $26,254,000 | -38.2% | 285,000 | -46.2% | 1.49% | -43.8% |
| AIMT | AIMMUNE THERAPEUTICS INC | $25,534,000 | +20.6% | 1,030,000 | 0.0% | 1.45% | +9.8% | |
| FPRX | FIVE PRIME THERAPEUTICS INC | $24,587,000 | +35.9% | 601,000 | 0.0% | 1.39% | +23.6% | |
| XLRN | ACCELERON PHARMA INC | $24,404,000 | +22.8% | 653,900 | 0.0% | 1.38% | +11.8% | |
| SNA | Buy | SNAP ON INC | $24,363,000 | -3.6% | 163,500 | +2.2% | 1.38% | -12.3% |
| ARW | ARROW ELECTRS INC | $23,721,000 | +2.5% | 295,000 | 0.0% | 1.34% | -6.7% | |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $23,158,000 | -16.1% | 2,207,610 | 0.0% | 1.31% | -23.7% | |
| IPHI | INPHI CORP | $22,028,000 | +15.7% | 555,000 | 0.0% | 1.25% | +5.3% | |
| SPLK | Sell | SPLUNK INC | $21,988,000 | -22.7% | 331,000 | -33.8% | 1.25% | -29.6% |
| IDTI | INTEGRATED DEVICE TECHNOLOGY | $21,955,000 | +3.1% | 826,000 | 0.0% | 1.24% | -6.2% | |
| CAFD | Sell | 8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt | $21,923,000 | -1.5% | 1,458,600 | -0.8% | 1.24% | -10.4% |
| PEGI | Buy | PATTERN ENERGY GROUP INCcl a | $21,570,000 | +2.1% | 895,000 | +1.0% | 1.22% | -7.1% |
| ELLI | New | ELLIE MAE INC | $19,875,000 | – | 242,000 | +100.0% | 1.13% | – |
| CRUS | CIRRUS LOGIC INC | $19,728,000 | -15.0% | 370,000 | 0.0% | 1.12% | -22.6% | |
| VCYT | VERACYTE INC | $18,711,000 | +5.3% | 2,133,500 | 0.0% | 1.06% | -4.2% | |
| HUBS | HUBSPOT INC | $17,482,000 | +27.8% | 208,000 | 0.0% | 0.99% | +16.5% | |
| HASI | Buy | HANNON ARMSTRONG SUST INFR C | $17,181,000 | +7.3% | 705,000 | +0.7% | 0.97% | -2.3% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $16,442,000 | +22.4% | 236,000 | -10.9% | 0.93% | +11.5% |
| AY | Sell | ATLANTICA YIELD PLC | $15,918,000 | -21.9% | 808,000 | -15.3% | 0.90% | -28.9% |
| DOOR | Sell | MASONITE INTL CORP NEW | $15,570,000 | -41.1% | 225,000 | -35.7% | 0.88% | -46.4% |
| 3106PS | DELPHI AUTOMOTIVE PLC | $15,547,000 | +12.3% | 158,000 | 0.0% | 0.88% | +2.2% | |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $14,285,000 | -7.7% | 214,000 | -28.9% | 0.81% | -16.0% |
| CYBR | Sell | CYBERARK SOFTWARE LTD | $14,022,000 | -49.0% | 342,000 | -37.8% | 0.80% | -53.5% |
| PFPT | Sell | PROOFPOINT INC | $13,781,000 | -40.1% | 158,000 | -40.4% | 0.78% | -45.5% |
| FIVN | New | FIVE9 INC | $13,766,000 | – | 576,000 | +100.0% | 0.78% | – |
| TWLO | Sell | TWILIO INCcl a | $13,641,000 | -29.5% | 457,000 | -31.3% | 0.77% | -35.9% |
| VMC | VULCAN MATLS CO | $13,156,000 | -5.6% | 110,000 | 0.0% | 0.75% | -14.1% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $12,608,000 | +35.1% | 334,700 | 0.0% | 0.72% | +23.1% | |
| STML | STEMLINE THERAPEUTICS INC | $12,059,000 | +20.7% | 1,086,400 | 0.0% | 0.68% | +9.8% | |
| AKCA | New | AKCEA THERAPEUTICS INC | $11,621,000 | – | 420,000 | +100.0% | 0.66% | – |
| VYGR | Buy | VOYAGER THERAPEUTICS INC | $11,560,000 | +330.1% | 561,425 | +87.1% | 0.66% | +292.2% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $10,574,000 | +47.3% | 90,000 | 0.0% | 0.60% | +34.0% | |
| TSLA | TESLA INC | $10,233,000 | -5.7% | 30,000 | 0.0% | 0.58% | -14.1% | |
| PANW | Buy | PALO ALTO NETWORKS INC | $9,997,000 | +14.9% | 69,372 | +6.7% | 0.57% | +4.6% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $9,906,000 | +53.6% | 159,000 | +96.3% | 0.56% | +39.6% |
| WVE | WAVE LIFE SCIENCES LTD | $9,429,000 | +16.9% | 433,500 | 0.0% | 0.53% | +6.4% | |
| MYOV | MYOVANT SCIENCES LTD | $8,509,000 | +32.2% | 550,000 | 0.0% | 0.48% | +20.2% | |
| PRTA | PROTHENA CORP PLC | $7,772,000 | +19.7% | 120,000 | 0.0% | 0.44% | +8.9% | |
| CERN | CERNER CORP | $7,717,000 | +7.3% | 108,200 | 0.0% | 0.44% | -2.5% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $7,660,000 | +33.2% | 125,000 | 0.0% | 0.43% | +21.2% | |
| SRPT | New | SAREPTA THERAPEUTICS INC | $7,303,000 | – | 161,000 | +100.0% | 0.41% | – |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $7,215,000 | -2.4% | 170,000 | -17.9% | 0.41% | -11.1% |
| XNCR | Sell | XENCOR INC | $7,174,000 | -1.2% | 313,000 | -9.0% | 0.41% | -10.0% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $6,980,000 | +2.5% | 75,000 | 0.0% | 0.40% | -6.6% | |
| EXR | Buy | EXTRA SPACE STORAGE INC | $6,553,000 | +3.1% | 82,000 | +0.6% | 0.37% | -6.3% |
| GWPH | GW PHARMACEUTICALS PLCads | $6,445,000 | +1.2% | 63,500 | 0.0% | 0.36% | -7.8% | |
| BOLD | AUDENTES THERAPEUTICS INC | $6,302,000 | +46.4% | 225,000 | 0.0% | 0.36% | +33.2% | |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $5,900,000 | +13.5% | 190,000 | 0.0% | 0.33% | +3.1% | |
| GLPG | GALAPAGOS NVspon adr | $5,291,000 | +33.0% | 52,000 | 0.0% | 0.30% | +21.0% | |
| EPZM | EPIZYME INC | $5,239,000 | +26.1% | 275,000 | 0.0% | 0.30% | +14.7% | |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $5,200,000 | -28.6% | 130,000 | -23.1% | 0.30% | -34.9% |
| EXAS | EXACT SCIENCES CORP | $4,712,000 | +33.2% | 100,000 | 0.0% | 0.27% | +21.4% | |
| INCY | INCYTE CORP | $4,670,000 | -7.3% | 40,000 | 0.0% | 0.26% | -15.6% | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $4,655,000 | -14.2% | 87,400 | 0.0% | 0.26% | -21.9% | |
| ATHN | ATHENAHEALTH INC | $4,601,000 | -11.5% | 37,000 | 0.0% | 0.26% | -19.4% | |
| RXDX | IGNYTA INC | $4,248,000 | +19.3% | 344,000 | 0.0% | 0.24% | +8.6% | |
| RGEN | REPLIGEN CORP | $4,215,000 | -7.5% | 110,000 | 0.0% | 0.24% | -15.8% | |
| ATRC | ATRICURE INC | $4,027,000 | -7.7% | 180,000 | 0.0% | 0.23% | -16.2% | |
| ACHN | ACHILLION PHARMACEUTICALS IN | $3,817,000 | -2.2% | 850,000 | 0.0% | 0.22% | -11.1% | |
| ACRS | ACLARIS THERAPEUTICS INC | $3,613,000 | -4.8% | 140,000 | 0.0% | 0.20% | -13.1% | |
| REGN | REGENERON PHARMACEUTICALS | $3,353,000 | -9.0% | 7,500 | 0.0% | 0.19% | -17.0% | |
| DERM | DERMIRA INC | $3,348,000 | -7.3% | 124,000 | 0.0% | 0.19% | -15.6% | |
| TSRO | TESARO INC | $3,357,000 | -7.7% | 26,000 | 0.0% | 0.19% | -15.9% | |
| TTPH | Sell | TETRAPHASE PHARMACEUTICALS I | $3,172,000 | -25.9% | 463,700 | -22.7% | 0.18% | -32.3% |
| MYOK | New | MYOKARDIA INC | $3,128,000 | – | 73,000 | +100.0% | 0.18% | – |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $3,028,000 | -16.5% | 192,000 | 0.0% | 0.17% | -23.9% | |
| TCON | TRACON PHARMACEUTICALS INC | $2,835,000 | +31.2% | 900,000 | 0.0% | 0.16% | +20.1% | |
| NTUS | NATUS MEDICAL INC DEL | $2,813,000 | +0.5% | 75,000 | 0.0% | 0.16% | -8.6% | |
| MGNX | MACROGENICS INC | $2,717,000 | +5.6% | 147,000 | 0.0% | 0.15% | -3.8% | |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $2,637,000 | +92.9% | 396,000 | +108.5% | 0.15% | +75.3% |
| SNDX | SYNDAX PHARMACEUTICALS INC | $2,633,000 | -16.2% | 225,000 | 0.0% | 0.15% | -24.0% | |
| AQXP | AQUINOX PHARMACEUTICALS INC | $2,483,000 | +0.9% | 175,000 | 0.0% | 0.14% | -7.8% | |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $2,395,000 | – | 20,000 | +100.0% | 0.14% | – |
| SEP | Sell | SPECTRA ENERGY PARTNERS LP | $2,219,000 | -1.5% | 50,000 | -4.8% | 0.13% | -10.0% |
| PTGX | PROTAGONIST THERAPEUTICS INC | $2,209,000 | +56.2% | 125,000 | 0.0% | 0.12% | +42.0% | |
| SYRS | SYROS PHARMACEUTICALS INC | $2,208,000 | -8.5% | 150,000 | 0.0% | 0.12% | -16.7% | |
| DRNA | DICERNA PHARMACEUTICALS INC | $2,168,000 | +81.4% | 377,000 | 0.0% | 0.12% | +66.2% | |
| CDTX | CIDARA THERAPEUTICS INC | $2,138,000 | +8.0% | 264,000 | 0.0% | 0.12% | -1.6% | |
| BHVN | BIOHAVEN PHARMACTL HLDG CO L | $1,990,000 | +49.5% | 53,240 | 0.0% | 0.11% | +36.1% | |
| ABB | Buy | ABB LTDsponsored adr | $1,980,000 | +17.0% | 80,000 | +17.6% | 0.11% | +6.7% |
| CHRS | COHERUS BIOSCIENCES INC | $1,936,000 | -7.0% | 145,000 | 0.0% | 0.11% | -15.4% | |
| JCI | Buy | JOHNSON CTLS INTL PLC | $1,853,000 | +4.2% | 46,000 | +12.2% | 0.10% | -5.4% |
| BEP | Buy | BROOKFIELD RENEWABLE PARTNERpartnership unit | $1,676,000 | +8.2% | 50,000 | +3.1% | 0.10% | -1.0% |
| FHB | Buy | FIRST HAWAIIAN INC | $1,590,000 | +23.6% | 52,500 | +25.0% | 0.09% | +12.5% |
| HMC | Buy | HONDA MOTOR LTD | $1,537,000 | +12.2% | 52,000 | +4.0% | 0.09% | +2.4% |
| BCRX | BIOCRYST PHARMACEUTICALS | $1,520,000 | -5.7% | 290,000 | 0.0% | 0.09% | -14.0% | |
| RARX | RA PHARMACEUTICALS INC | $1,460,000 | -22.1% | 100,000 | 0.0% | 0.08% | -29.1% | |
| PAYC | New | PAYCOM SOFTWARE INC | $1,378,000 | – | 18,382 | +100.0% | 0.08% | – |
| KALA | New | KALA PHARMACEUTICALS INC | $1,370,000 | – | 60,000 | +100.0% | 0.08% | – |
| NYLD | Buy | NRG YIELD INCcl c | $1,370,000 | +12.9% | 71,000 | +2.9% | 0.08% | +2.6% |
| BDN | Buy | BRANDYWINE RLTY TRsh ben int new | $1,382,000 | +16.8% | 79,000 | +17.0% | 0.08% | +5.4% |
| PTCT | New | PTC THERAPEUTICS INC | $1,365,000 | – | 68,200 | +100.0% | 0.08% | – |
| TSM | Sell | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $1,314,000 | -3.6% | 35,000 | -10.3% | 0.07% | -12.9% |
| New | HANNON ARMSTRONG SUST INFR Cnote | $1,297,000 | – | 1,250,000 | +100.0% | 0.07% | – | |
| APU | Buy | AMERIGAS PARTNERS L Punit l p int | $1,101,000 | +21.9% | 24,500 | +22.5% | 0.06% | +10.7% |
| CMTA | New | CLEMENTIA PHARMACEUTICALS IN | $1,013,000 | – | 60,000 | +100.0% | 0.06% | – |
| BG | BUNGE LIMITED | $938,000 | -6.9% | 13,500 | 0.0% | 0.05% | -15.9% | |
| WBK | WESTPAC BKG CORPsponsored adr | $820,000 | +7.8% | 32,500 | 0.0% | 0.05% | -2.1% | |
| ETN | Buy | EATON CORP PLC | $806,000 | +15.1% | 10,500 | +16.7% | 0.05% | +4.5% |
| GLBL | TERRAFORM GLOBAL INCcl a | $760,000 | -5.9% | 160,000 | 0.0% | 0.04% | -14.0% | |
| ESSA PHARMA INC | $699,000 | -46.6% | 2,719,410 | 0.0% | 0.04% | -50.6% | ||
| TERP | Buy | TERRAFORM PWR INC | $694,000 | +34.5% | 52,500 | +22.1% | 0.04% | +21.9% |
| CCIPRA | New | CROWN CASTLE INTL CORP NEW6.875% con pfd a | $641,000 | – | 600 | +100.0% | 0.04% | – |
| ERIC | Buy | ERICSSONadr b sek 10 | $604,000 | -6.4% | 105,000 | +16.7% | 0.03% | -15.0% |
| LXP | Buy | LEXINGTON REALTY TRUST | $562,000 | +13.3% | 55,000 | +10.0% | 0.03% | +3.2% |
| LPT | LIBERTY PPTY TRsh ben int | $493,000 | +0.8% | 12,000 | 0.0% | 0.03% | -6.7% | |
| VTR | VENTAS INC | $456,000 | -6.2% | 7,000 | 0.0% | 0.03% | -13.3% | |
| WELL | WELLTOWER INC | $387,000 | -6.1% | 5,500 | 0.0% | 0.02% | -15.4% | |
| ACORDA THERAPEUTICS INCnote | $363,000 | +5.2% | 400,000 | 0.0% | 0.02% | 0.0% | ||
| AYI | ACUITY BRANDS INC | $343,000 | -15.7% | 2,000 | 0.0% | 0.02% | -24.0% | |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $25,000 | – | 13,099 | +100.0% | 0.00% | – |
| HTGC | Exit | HERCULES CAPITAL INC | $0 | – | -100,000 | -100.0% | -0.08% | – |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.14% | – |
| KITE | Exit | KITE PHARMA INC | $0 | – | -85,000 | -100.0% | -0.55% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 43 | Q2 2024 | 3.2% |
| PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
| ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
| REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
| VERACYTE INC | 41 | Q2 2024 | 1.5% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
| COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
| BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
| Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
| Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
| Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
| Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
| MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
| Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
| Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-08-13 |
| SC 13G/A | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.